Protective Factors Against Elderly Suicide

Status Terminated

Clinical Trial Summary

Suicidal intentionality is generally stronger among the elderly, suicidal acts are more violent and are combined with a greater physical fragility. The suicide of an older adult is a situation that often leads to helplessness feelings.

Analysis of the literature reveals two types of major interventions in order to reduce suicide rate: reducing risk factors and increasing protective factors. Risk factors are well documented, particularly from studies using psychological autopsies. However, protective factors are much less studied for the elderly. Yet the identification of relevant and available protective mechanisms in a suicidal crisis is essential to effectively guide nurses and health professionals in therapeutic commitment and intervention.

Clinical Trial Description

France has a suicide rate (16.2 per 100 000 inhabitants) well above the European average rate (10.2 per 100 000 inhabitants). The Poitou-Charentes region is in a situation of excess mortality by suicide compared to France (+ 25%). While the ratio of suicide attempts per suicide is about 200/1 before 25 years, it is estimated to be 4/1 after 65 years, or even 1/1 in elderly men. In France, suicide attempts are not systematically recorded and the frequency of suicidal ideation is poorly understood. The consensus conference on suicidal crisis highlights a number of clinical points specific to the elderly population (suicidal ideas are not always clearly expressed or unidentified, there are various manifestations of the psychic crisis, greater vulnerability of this population), but the complexity of interactions between suicidal risk factors limits our predictive capabilities of suicidal intention in an elderly person. Analysis of the literature reveals two types of major interventions in order to reduce the suicide rate: those aimed at reducing risk factors and those aimed at increasing protective factors. The objective of our research is to determine the effect of protective factor methodical search on post-crisis patient care. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03162744
Study type	Observational
Source	Groupe Hospitalier de la Rochelle Ré Aunis
Contact
Status	Terminated
Phase
Start date	February 16, 2018
Completion date	May 27, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03185026` - Psychoeducation for Suicidal Behavior	N/A
Recruiting	`NCT05609487` - Evaluation of the Safety Plan to Prevent Suicidal Reiteration	N/A
Recruiting	`NCT06322199` - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Completed	`NCT03134885` - Evaluation of a Regional Post-discharge Monitoring System for Suicide Attempters
Completed	`NCT01535482` - Cognitive Therapy for Suicidal Older Men	N/A
Completed	`NCT01360736` - A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)	N/A
Completed	`NCT01118208` - Blister Packaging Medication to Increase Treatment Adherence and Clinical Response	N/A
Completed	`NCT05580757` - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Not yet recruiting	`NCT05427734` - Treating Drivers of Suicide Using Jaspr Health	N/A
Recruiting	`NCT06406972` - Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
Recruiting	`NCT05537376` - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness	N/A
Completed	`NCT03227991` - Safety Planning Intervention to Reduce Short Term Risk	N/A
Recruiting	`NCT04962373` - Brief Admission for Adolescents Who Self-harm
Completed	`NCT02985047` - Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide	N/A
Enrolling by invitation	`NCT06060535` - Implementation of Suicide Risk Models in Health Systems	N/A
Recruiting	`NCT04994873` - Skills to Enhance Positivity in Suicidal Youth	N/A
Recruiting	`NCT04592809` - Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents	Phase 3
Completed	`NCT01176929` - Randomized Controlled and Prospective Trial of a Cohort of People Who Made a Suicide Attempt	N/A
Completed	`NCT00558805` - Family Intervention for Suicidal Youth: Emergency Care	Phase 2
Recruiting	`NCT05390918` - Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Protective Factors Against Elderly Suicide — ProFAES

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms